Category: Workers Comp

523 posts found

Clinical Developments

Florida Publishes 2020 COVID-19 Report

A report on claim data up to July 31st.

Regulatory Developments

COVID-19 Telehealth Updates

Telehealth extensions in Colorado, Texas, and New York.

Medmonitor

FDA Issues Naloxone Recommendations for Opioids and OUD Drugs

The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.

This Month's Must Read

Overcoming Obstacles to Patient Recovery Amid a Global Pandemic

Healthesystems’ VP of Clinical Services addresses COVID-19 disruptions to workers’ comp, along with helpful strategies

Clinical Insights

American Medical Association Publishes Opioid Task Force Report

AMA hopes to shift from a crisis-reaction framework to a more holistic model that prevents overdose while helping pain patients receive care.

Industry Trends

California Releases Online COVID-19 Interactive App

Information from nearly 15,000 COVID-19 claims broken down by industry, demographics, and more.

Legislation & Policy

Connecticut Enacts Major COVID-19 Presumption

Beyond first responders and healthcare workers, essential workers including grocery store workers are now covered by workers’ comp.

Regulatory Developments

Department of Labor Audit: COVID-19’s Impact on Comp

A new report on how federal workers’ comp claims have been impacted.

COVID-19 Developments

Returning to Work in the COVID-19 Era

With cases increasing as individuals return to work, injured workers face barriers to care, risk of infection, and more.

Healthe Developments

Driving a More Personalized Claim Experience in a Digital World

As complex claims continue to impact workers’ comp, our new article in WorkCompWire addresses the need for early warnings and clinical guidance.

Regulatory Developments

Virginia Adopts Workplace Safety Standards for COVID-19

Standards are in place for PPE, social distancing, testing procedures, and more.

Medmonitor

FDA Approves Hulio for Rheumatoid Arthritis and More

Subcutaneous injections of the new biologic, adalimumab-fkjp, were approved for seven indications.

This Month's Must Read

A New Routine: The Growth of Complex Claims and How to Manage Them

Strategies for anticipating and mitigating complex claim risks.

Clinical Insights

American Medical Association Asks CDC to Revise Opioid Guidelines

The AMA suggests that prescription medications are no longer a significant factor in the opioid epidemic, and that opioid prescription limits should change.

Legislation & Policy

States Pass COVID-19 Liability Limitations

Arkansas and Louisiana enacted policies to protect businesses from civil liability stemming from COVID-19 exposure.

Prev 1 2 3 4 5 … 21 22 23 24 25 … 31 32 33 34 35 Next